Supramarginal Resection in Glioblastoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Glioblastoma
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Outcomes Assessor)Masking Description: Participants will be masked until postoperative period. Outcome assessor will be masked until all predefined outcomes have been analysedPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04243005
- Collaborators
- Turku University Hospital
- Odense University Hospital
- Sahlgrenska University Hospital, Sweden
- Karolinska University Hospital
- Rikshospitalet University Hospital
- Aarhus University Hospital
- Norwegian University of Science and Technology
- University Hospital of North Norway
- Kuopio University Hospital
- Tampere University Hospital
- University Hospital, Linkoeping
- Helsinki University Central Hospital
- Uppsala University Hospital
- University Hospital, Umeå
- Skane University Hospital
- Haukeland University Hospital
- Ullevaal University Hospital
- Rigshospitalet, Denmark
- Oulu University Hospital
- Investigators
- Principal Investigator: Asgeir S Jakola, MD, PhD St.Olavs University Hospital and Sahlgrenska University Hospital Study Director: Geir Bråthen, MD, PhD St. Olavs Hospital
Get Well Soon